NOVTNovanta Inc.

Filed with the SEC on November 9, 2026 | Form 8-K (Items 2.02, 9.01) Current Price: $122.97 | Today's Change: -15.76%

---

What Happened

Novanta Inc. filed an 8-K with the SEC on November 9, 2026, disclosing its third-quarter fiscal 2026 financial results under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). For Q3 FY2026, the company reported revenue of $722.25 million, operating income of $69.18 million, and net income of $36.36 million, translating to both basic and diluted earnings per share of $1.01. The market reaction has been severe, with shares tumbling 15.76% to $122.97 as of today's session, suggesting the results fell meaningfully short of investor expectations.

---

Why It Matters

The magnitude of the share price decline — nearly 16% in a single session — signals that the market viewed these results as a significant disappointment, whether against consensus forecasts, prior guidance, or the implied trajectory embedded in the stock's valuation. At the operating income level, Novanta posted a 9.6% operating margin on Q3 revenues of $722.25 million, a figure that investors appear to have found underwhelming. For context, our existing StockWatch coverage, initiated on September 22, 2026, provides a broader framework for assessing Novanta's business trajectory — the sharp reaction today materially alters the near-term risk/reward landscape that was in place at the time of that coverage. The stock is now trading well below the price target referenced in that prior research.

Key investor concerns likely center on:

• Revenue quality and growth trajectory relative to prior periods
• Operating margin compression or failure to expand as expected
• Near-term earnings power, with diluted EPS of $1.01 for the quarter
• Forward guidance, the details of which are not captured in the XBRL structured data provided

---

Analysis

A 15.76% single-session decline on an earnings release is a consequential market signal — it suggests the gap between expectations and reported results was wide, not narrow. While the absolute figures ($722M in revenue, $36M in net income) are not trivial for a precision motion and sensing technology company, context matters: valuation multiples for growth-oriented industrial technology companies like Novanta are built on the assumption of continued earnings momentum. Any deceleration — in revenue growth, margin expansion, or forward guidance — tends to be punished harshly.

What to watch next:

• Management's commentary and guidance from the accompanying earnings call or press release, which will clarify whether this is a one-quarter stumble or a more structural shift in the demand environment
• Segment-level performance across Novanta's precision motion, medical, and robotics end markets, which are not disaggregated in the structured XBRL data available here
• Whether the selloff stabilizes around current levels or continues, as this will be a key signal of institutional confidence in the revised earnings outlook
• Any revision to forward guidance that management may have issued alongside these results

The comparison point from the structured data — Q1 FY2018 revenues of $108.97 million — illustrates how dramatically Novanta has scaled over the intervening years. The question now is whether the Q3 FY2026 results represent a speed bump on a continued growth path, or a more significant inflection point.

---

Disclaimer

This report is a news and informational summary based solely on data contained in Novanta Inc.'s SEC filing dated November 9, 2026, and publicly available market data. It does not constitute investment advice, an offer or solicitation to buy or sell any security, or an equity research recommendation. No rating or price target is issued or implied by this report. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.

Existing Coverage

StockWatch has full coverage on NOVT, published 2026-09-22. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-09. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1076930/000119312526453760/novt-20261109.htm